The present invention is directed to compounds that modulate the bioactivity of an orexin receptor such as OX1 or OX2, or both； to pharmaceutical compositions and combinations comprising a compound of the invention； to methods of treatment of malconditions in patients wherein modulation of an orexin receptor is medically indicated； and to methods of preparation of compounds of the invention. For example, orexin receptor-modulatory compounds of the present invention can be used in treatment of an eating disorder, obesity, alcoholism or an alcohol-related disorder, drug abuse or addiction including addiction to cocaine, opiates, amphetamines, or nicotine, a sleep disorder, a cognitive dysfunction in a psychiatric or neurologic disorder, depression, anxiety, panic disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, headache, migraine, pain, gastrointestinal diseases, epilepsy, inflammations, immune-related diseases, endocrine-related diseases, cancer, hypertension, behavior disorder, mood disorder, manic depression, dementia, sex disorder, psychosexual disorder, or renal disease.La présente invention concerne des composés qui peuvent moduler la bioactivité d'un récepteur de l'orexine, tel que OX1 ou OX2, ou les deux ； des compositions pharmaceutiques et des combinaisons comprenant un composé de l'invention ； des procédés de traitement d'états pathologiques de patients chez lesquels la modulation d'un récepteur de l'orexine est médicalement indiquée ； et des procédés de préparation de composés de l'invention.
